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Abstract
Background
Snakebite is a major problem affecting the rural poor in many of the poorest countries in the
tropics. However, the scale of the socio-economic burden has rarely been studied. We
undertook a comprehensive assessment of the burden in Sri Lanka.
Methods
Data from a representative nation-wide community based household survey were used to
estimate the number of bites and deaths nationally, and household and out of pocket costs
were derived from household questionnaires. Health system costs were obtained from hos-
pital cost accounting systems and estimates of antivenom usage. DALYs lost to snakebite
were estimated using standard approaches using disability weights for poisoning.
Findings
79% of victims suffered economic loss following a snakebite with a median out of pocket
expenditure of $11.82 (IQR 2–28.57) and a median estimated loss of income of $28.57 and
$33.21 for those in employment or self-employment, respectively. Family members also
lost income to help care for patients. Estimated health system costs for Sri Lanka were
$ 10,260,652 annually. The annual estimated total number of DALYS was 11,101 to 15,076
per year for envenoming following snakebite.
Interpretation
Snakebite places a considerable economic burden on the households of victims in Sri
Lanka, despite a health system which is accessible and free at the point of care. The disabil-
ity burden is also considerable, similar to that of meningitis or dengue, although the relatively
low case fatality rate and limited physical sequelae following bites by Sri Lankan snakes
means that this burden may be less than in countries on the African continent.
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Author summary
Snakebite predominantly affects poor people in the rural tropics. The effect that snakebite
has on these populations, both economically and in terms of death and disability, is poorly
understood. We used data from a national household survey of snakebite in Sri Lanka to
estimate the burden of death and disability and to calculate the financial cost of a snake-
bite episode for the Sri Lankan health system and for Sri Lankan households. We found
that the burden of snakebite was considerable, similar to that of common diseases like
meningitis or dengue and that treating snakebite cost the Sri Lankan government over
$10 million each year. Despite health care being free in Sri Lanka, almost 80% of house-
holds experienced additional costs and loss of income following a snakebite; such costs
are disastrous for poor rural workers.
Introduction
Snakebite is a major public health problem in rural communities in Asia, Africa and Latin
America [1]. The problem has been extensively studied from a bio-medical perspective but
rarely from a socio-economic viewpoint. However, the negative social and economic conse-
quences of snakebite are likely to be considerable. Firstly, snakebite is a problem of tropical
low and middle income countries that are already facing the considerable dual burden of com-
municable and non-communicable diseases; snakebite mortality is strongly associated with
low per capita Gross Domestic Product and a low Human Development Index [2]. In such set-
tings, the ill-health associated with snakebite can exert a considerable burden on the economic
development of these countries. Secondly, the victims are usually economically productive,
young individuals in these communities whose future productive lifespan can be negatively
affected by snakebite. Thirdly, most of those affected are rural daily wage earners employed in
the informal sector that include farming and other labour intensive occupations, for whom
snakebite results in a considerable opportunity cost for being away from work.
Very few studies have attempted to formally investigate the socio-economic burden associ-
ated with snakebite. A household survey in rural India demonstrated a significant reduction in
medium and long-term family income due to snakebite, in addition to the immediate costs of
a bite [3]. A West African study estimated years of life lived with disability (YLD) due to limb
amputations resulting from snakebite using DALYs for 16 countries in the region [4]. Disabil-
ity-adjusted-life years (DALYs) is a widely used metric for estimating disease burden based on
strong economic and ethical principles [5]. The Global Burden of Disease (GBD) Study used
DALYs successfully to describe disability and the burden of important diseases for the period
1990–2020 [6]. Since then, the method of GBD estimation has been improved in repeated
attempts to estimate the global disease burden [7]. National estimates of the overall social and
economic impact of snakebite have not been attempted for any country to date. This paper
estimates the economic cost and disease burden of snakebite for Sri Lanka using data from a
recent country-wide community based survey [8].
Methods
Ethics statement
The study was approved by the Ethics Review Committee of the Faculty of Medicine, Univer-
sity of Kelaniya. Permission for conducting the study was obtained from District and
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Divisional level public administrators before data collection. Grama Niladharis of the sampled
GN divisions were informed about the study through the public administration system.
Written informed consent was obtained from the participants before data collection. The
information sheet was read out to illiterate patients in the presence of a family member and a
witnessed thumb print was used to signify consent.
A country-wide community based cross sectional survey was conducted between August
2012 and June 2013 [8]. The survey was designed to sample approximately 1% of the popula-
tion of Sri Lanka distributed equally among its nine provinces. A Grama Niladhari (GN)
division (the smallest administrative unit in the country) was defined as a cluster for data col-
lection, and 125 clusters were allocated to each of the 9 provinces. Within each province the
number of clusters was divided among the districts in proportion to each districts’ population.
The clusters were selected using simple random sampling from the list of GN divisions avail-
able at the Department of Census and Statistics, Sri Lanka. 40 households were sampled con-
secutively from the randomly selected starting point in each cluster.
Information related to all residents of the sampled households was obtained by trained data
collectors using an interviewer administered questionnaire. They were assisted by local field
volunteers recruited from within the cluster. The respondent of each household was either the
head of the household or a responsible adult present in the house. A two part structured ques-
tionnaire was used for data collection. The questionnaire was translated into Sinhala and
Tamil and was pre-tested in a GN division within each province which was not selected for the
study. Based on the findings of the pretesting, the questionnaire was fine-tuned prior to use.
In the first phase of data collection, the research assistant screened the households for
snakebite within the previous 12 months and obtained socio-demographic data from the
households. In the second phase of data collection, instruments were administered to the
households which had reported snakebites within the previous 12 months in order to obtain
details of the bite, clinical manifestations of envenoming, residual disability and deaths due to
snakebite. Detailed information on the household costs of snakebite was recorded. Only sys-
temic symptoms or signs were considered to reflect envenoming.
Data were double entered into databases created in Epidata software. Discrepancies were
corrected by referring to the original data sheets. Data analysis was performed in SPSS version
22.
Estimating the cost of snakebite
The median out-of-pocket cost of different cost elements were estimated based on the data
reported by the victims or a household member for a number of different out of pocket costs.
Victims or household members were also asked to estimate the number of days lost off work
due to the snakebite and the amount of wages lost by the victim and the household due to the
snakebite. The total sum spent by patients for a particular cost item and the proportion of
patients that incurred that cost was applied to the estimated national incidence of snakebite to
estimate the total annual out-of-pocket cost of snakebite for the entire country. The income
lost by the patient or family members and the proportion of patients who lost income in differ-
ent ways were applied to the estimated national incidence of snakebite to arrive at the total
annual lost income due to snakebite for the entire country. The health system cost of snakebite
was estimated based on cost data obtained from the cost accounting system maintained at the
Teaching Hospital, Kurunegala, Sri Lanka. The average cost of a patient day in the medical
ward excluding drug costs was obtained from this database. This cost included the cost of
nursing and medical care, investigations and the hotel costs of maintaining a patient in a
medical ward. The cost of a patient day amounted to LKR 3214.00 (USD 22.96). Ancillary
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treatments are rarely used in Sri Lanka and were therefore not included. The cost of a vial of
anti-venom was obtained from the price list issued by the Medical Supplies Division, Ministry
of Health, Sri Lanka [9]. The number of anti-venom vials used was estimated based on the
national guidelines for management of snakebite and the assumption that the 30%, 65% and
5% of envenomed patients received respectively, 10, 20 and 30 vials of anti-venom during the
management of envenoming. This assumption was based on the consensus arrived among five
specialist physicians experienced in managing snakebite in different parts of the country. The
median duration of hospitalization for a snakebite with and without envenoming was esti-
mated based on the data reported by the households of victims. The costs were extrapolated
for the country using the estimated national incidence of snakebite from the nationwide
survey.
Estimating disability-adjusted life years
DALYs were calculated using the following formula: DALY = YLD + YLL. The template devel-
oped by the World Health Organization [10] was used for estimation of DALYs. Population
data from the 2012 national census were obtained from the Department of Census and Statis-
tics, Sri Lanka ([11]. For envenoming, the disability weight used for the higher estimate was
0.6 which is the accepted disability weight used for poisoning in the original GBD study [6].
We used a disability weight of 0.163 for the lower estimate based on the disability weight used
for poisoning in the 2013 GBD study. In using the disability weight for poisoning, we have
assumed that snakebite envenoming and poisoning are comparable in terms of the associated
disability. The duration of an episode of snakebite with envenoming was considered to be 0.3
years. For snakebites without envenoming disability weights of 0.006 (lower estimate) and
0.108 (higher estimate) were used. These are the weights used for open wounds in the GBD
studies [6,12]. The duration of illness for snakebite without envenoming was considered to be
0.04 years. The standard discount rate used was 0.03. Beta and constant values used for stan-
dard age weighting were 0.04 and 0.1658.
Results
The total sample was 165,665 individuals living in 44,136 households approximately equally
distributed among the nine provinces of the country. The survey reported 695 snakebites and
five deaths. Envenoming had been observed in 323 bite victims. Residual physical disability fol-
lowing the bite was reported by 59 (8.5%) victims. For the entire country, the extrapolated
number of snakebites, envenoming and deaths were 80,277, 30,458, and 429, respectively [8].
Household cost of snakebite
551 (79.3%) victims incurred an economic loss following a bite and 550 (79.1%) victims
incurred out-of-pocket expenditure for healthcare. The median total out-of-pocket expendi-
ture per snakebite episode (envenomed and non-envenomed) was USD 11.82 (Inter-quartile
range 5–28.57). Details of out-of-pocket expenditure are given in Table 1 and include travel,
food, costs of keeping carers with the victim during the hospital stay, fees for laboratory inves-
tigation, purchase of pharmaceuticals and medical products that were not available in the hos-
pital and other unspecified direct costs. In addition, a cost was often incurred for religious and
cultural rituals which were organized for 138 (19.9%) victims necessitating expenditure for 101
(14.5%) families. The median cost of conducting these activities was USD 7.14 (Inter quartile
range 3.57–14.29). The annual estimated national direct out-of–pocket expenditure for snake-
bite was USD 1,981,699.
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442 of the victims (63.6%) were employed, but only 134 (19.3%) reported that they had to
stop work temporarily due to the bite. The median total income lost due to the bite by these
victims was USD 28.57 (Inter-quartile range 17.14–56.07) (Table 2). Self-employed victims
(n = 158, 22.7%) lost a median income of USD 33.21 (Inter-quartile range 17.86–54.46) either
due to lost work or costs of a replacement. National annual estimated lost income was USD
910,259 and USD 844,142 for employed and self-employed victims respectively. At least one
family member of 103 (14.8%) bite victims had lost at least one workday due to the bite. The
median economic loss by these family members due to the bite was USD 28.57 (Inter-quartile
range 14.29–81.07). This amounted to an annual estimated lost income of USD 101,037 for
Table 1. Out-of-pocket expenditure following snakebite.
Cost item Number (%)
experiencing cost
(National survey)
Estimated number
of patients
incurring the cost
nationally
Mean expenditure
(SD) for those
experiencing cost
(USD)*
Median
cost (IQR)
USD*
Total cost for
survey
patients LKR
(USD)*
Estimated
national cost
(LKR)*
Estimated
national cost
(USD)*
Transport of victim 489 (70.4) 56,515 7.82 (14.22) 3.93 (2.2–
7.1)
535,110
(3,822)
61,844,052 441,743
Visits by family 288 (41.4) 33,235 16.89 (94.80) 7.14 (3.6–
14.3)
680,858
(4863.27)
78,570,540 561,218
Help and carers 78 (11.2) 8,991 11.17 (14.11) 7.14 (3.6–
11.6)
121,950
(871.07)
14,057,083 100,408
Food 225 (32.4) 26,010 10.15 (13.86) 7.14 (3.6–
14.3)
319,575
(2282.68)
36,942,870 263,878
Pharmaceuticals/
Medicines
126 (18.1) 14,530 15.23 (65.30) 5.71 (2.5–
8.9)
268.705
(1919.32)
30,986,378 221,331
Laboratory
Investigations
31 (4.5) 3,612 21.38 (36.58) 8.57 (4.6–
13.4)
92,780
(662.71)
10,810,366 77,217
Medical Products 12 (1.7) 1,365 4.55 (8.81) 1.96 (0.7–
3.6)
7,640 (5,457) 869,050.00 6,208
Unspecified costs 65 (9.4) 7,546 17.50 (95.23) 3.57 (1.4–
7.9)
159,220
(1137.29)
18,484,217 132,030
Religious/ cultural
rituals
101 (14.5) 11640 17.50 (95.23) 7.14 (3.6–
14.3)
215,825
(1541.61)
24,873,297 177,666
Total 277,437,853 1,981,699
*1 USD = 140 Sri Lankan Rupees (LKR)
https://doi.org/10.1371/journal.pntd.0005647.t001
Table 2. Indirect household costs of snakebite.
Cost item Number (%)
experiencing cost
(National survey)
Estimated number
of patients
incurring the cost
nationally
Mean expenditure
(SD) for those
experiencing cost
(USD)*
Median
cost (IQR)
USD*
Total cost for
survey patients
LKR (USD)*
Estimated
national cost
(LKR)*
Estimated
national cost
(USD)*
Employed
victims
125 (18.0) 14,450 62.99 (96.01) 28.57
(17.1–56.1)
1,102,390
(7874.2)
127,436,284 910,259
Self-
employed
158(22.7) 17,661 47.80 (80.66) 33.21
(17.9–54.5)
1,023,810
(7312.9)
118,179,794 844,142
Relatives 36 (5.2) 4,174 24.21 (12.07) 28.57
(14.3–81.1)
122,000 (871.4) 14,145,222 101,037
Total 259,761,300 1,855,438
*1 USD = 140 Sri Lankan Rupees (LKR)
https://doi.org/10.1371/journal.pntd.0005647.t002
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family members of victims. Overall, the estimated annual lost income amounted to a total of
USD 1,855,438, meaning that the total annual economic burden on households nationally was
USD 3,837,137.
Health system cost of snakebite
The estimated annual health system cost of snakebite management was USD 10,260,651.53
(Table 3). This comprised approximately USD 6.3 million for the snakebite anti-venom and
USD 3.9 million for the hospital management of patients (Table 2). Combining household and
health system costs meant that the estimated total annual economic burden of snakebite was
USD 14,097,789.
Disability burden of snakebite
The total YLL due to snakebite was 4,765 for males and 4,853 for females. Total YLD ranged
from 859–3,161 for males and 624–2,296 for females. The annual estimated total number of
DALYs for envenoming and death due to snakebite ranged from a lower estimate of 11, 101 to
an upper estimate of 15,076 per year. This comprised 5,624–7,927 DALYs for males and 5477–
7,150 DALYs for females, equating to 0.5–0.7 DALYs per 1000 population for snakebite enven-
oming (Tables 4 and 5). The total estimated DALYs due to snakebites without envenoming
ranged from 20–500 per year (S1 and S2 Tables).
Discussion
Snakebite is a major neglected tropical disease. The relative lack of data on the burden of
snakebite demonstrates the lack of attention to this condition which is confined to poor rural
areas of tropical, low and middle income countries [2]. We have estimated the societal and
Table 3. Estimated annual health system cost of snakebite in Sri Lanka.
Clinical
Presentation
Number of
Patients
Duration of Hospitalization
(Days)
Total ward cost without AVS
(USD)
Cost of AVS
(USD)
Total cost (USD)
Without envenoming 49 819 1 1,143,701.90 - 1,143,701.90
With envenoming 30 458 4 2 796 914.63 6 320,035.00 9,116,949.63
80 277 - 3 940 616.53 6,320,035.00 10,260,651.53
https://doi.org/10.1371/journal.pntd.0005647.t003
Table 4. Annual disease burden of snakebite envenoming in Sri Lanka (lower estimate)*.
Males Females Total
Population DALYs DALYs per 1,000 Population DALYs DALYs per 1,000 Population DALYs DALYs per 1,000
Age
0–4 879,223 34 0 864,639 99 0.1 1,743,862 133 0.1
5–14 1,711,177 346 0.2 1,676,627 278 0.2 3,387,804 624 0.2
15–29 2,305,753 1,349 0.6 2,424,227 1,025 0.4 4,729,980 2,374 0.5
30–44 2,144,526 1,827 0.9 2,263,175 1,580 0.7 4,407,701 3,407 0.8
45–59 1,700,304 1,645 1 1,869,215 2,019 1.1 3,569,519 3,664 1
60–69 709,192 326 0.5 842,007 384 0.5 1,551,199 710 0.5
70–79 298,235 97 0.3 397,365 92 0.2 695,600 189 0.3
80+ 108,224 165,550 273,774
Total 9,856,634 5,624 0.6 10,502,805 5,477 0.5 20,359,439 11,101 0.5
*Estimated using a disability weight of 0.163
https://doi.org/10.1371/journal.pntd.0005647.t004
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economic burden of snakebite using nationally representative data generated from a large
scale community survey conducted in Sri Lanka. We estimate that snakebite is responsible for
up to approximately 15,000 DALYs per year. This is three times greater than the estimate from
the Institute for Health Metrics and Evaluation for Sri Lanka and would suggest that the bur-
den of snakebite in Sri Lanka is equivalent to that of meningitis and greater than that of dengue
[13].
Given the numbers of snakebites in Sri Lanka, the estimated DALYs due to snakebite in
this paper are relatively modest compared to those estimated from West Africa [4]. The avail-
ability of antivenom and supportive facilities in an accessible and free health system has led to
a reduction in snakebite mortality over the last two decades in Sri Lanka to the point where
case fatality rates are now only 1.5% in envenomed patients [8]. This situation contrasts with
the limited access to healthcare facilities and poor availability of antivenom in many parts of
Africa, where snakebite occurs in the poorest rural populations [2]. The current crisis in anti-
venom supply for Africa means that many patients die because they simply cannot be treated
[14]. In addition, a major contributor to the burden calculation for West Africa was the dis-
ability that results from severe tissue damage and consequent amputation, an outcome that is
uncommon following envenoming by venomous species in Sri Lanka [4,15].
High quality facilities and emergency care coupled with adequate supplies of anti-venom
lead to the good outcomes following snakebite in Sri Lanka, but means the estimated health
system costs of managing snakebite are considerable at over USD 10 million and account for
0.7% of total government health expenditure [16]. It is unlikely that these costs will reduce in
the near future as there is no indication that the high incidence of bites is declining and
improving health seeking behaviour means that western standard healthcare facilities are
increasingly likely to be used.
Even more concerning is the economic burden that snakebite places on victims and their
households. Few studies have previously attempted to estimate the effect of snakebite on this
although one Tamil Nadu study demonstrated the ongoing adverse household consequences
of expenditure on snakebite, requiring loans and selling of household assets to pay for treat-
ment costs and the economic burden of snakebite upon households has also been noted in
Bangladesh [3,17]. Our research demonstrated the substantial household costs of an episode of
snakebite from both out of pocket costs and lost income. Some workers in the formal employ-
ment may be compensated by paid sick-leave, but only a few victims of snakebite have formal
employment. The median household cost of an episode of envenoming was $12 and around a
Table 5. Annual disease burden of snakebite envenoming in Sri Lanka (higher estimate)**.
Males Female Total
Age Population DALYs DALYs per 100 Population DALYs DALYs per 100 Population DALYs DALYs per 100
0–4 879,223 45 0.1 864,639 119 0.1 1,743,862 165 0.1
5–14 1,711,177 457 0.3 1,676,627 345 0.2 3,387,804 802 0.2
15–29 2,305,753 1,812 0.8 2,424,227 1,287 0.5 4,729,980 3,099 0.7
30–44 2,144,526 2,521 1.2 2,263,175 2,025 0.9 4,407,701 4,546 1.0
45–59 1,700,304 2,403 1.4 1,869,215 2,690 1.4 3,569,519 5,093 1.4
60–69 709,192 517 0.7 842,007 541 0.6 1,551,199 1,058 0.7
70–79 298,235 171 0.6 397,365 142 0.4 695,600 314 0.5
80+ 108,224 - - 165,550 - - 273,774 - -
Total 9,856,634 7927 0.8 10,502,805 7,150 0.7 20,359,439 15,076 0.7
**Estimated using a disability weight of 0.6.
https://doi.org/10.1371/journal.pntd.0005647.t005
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fifth of patients reported losing income of approximately $30. To put this in context, the
annual per capita expenditure on health in 2014 was $127 [18] and the mean per capita income
in the rural areas was $74 per month [19]. The national household economic burden of snake-
bite amounted to USD 3.8 million and it is highly likely in Sri Lanka that snakebite drives the
same catastrophic costs for the poor as many other diseases [19,20].
There are clearly limitations to this study. Many of the estimates depend on assumptions
about the duration of disability and recall of individuals about the costs that they incurred.
There were challenges in the estimation of disability burden as there are no accepted disability
weights for snakebite and so those for poisoning were used for envenomed individuals and
assumptions regarding wounds were made for non-envenomed. Despite this, to our knowl-
edge, this is the first ever comprehensive estimation of a national socio-economic burden from
snakebite. Our results demonstrate the extent of this burden in Sri Lanka and highlights the
considerable physical and economic impact of this disease, both upon the country and upon
the lives of poor rural workers.
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